Article Information
History
- May 13, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 13, 2020 - 03:39).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Osaid Alser, MD, MSc(Oxon)1,*,
- Heba Alghoul, MD2,
- Zahra Alkhateeb, BSc, MS3,
- Ayah Hamdan, BSc4,
- Loai Albaraqouni, MD, PhD5 and
- Kiran Saini, BM BCh(Oxon)6
- 1Ministry of Health, Gaza Strip, occupied Palestinian territory and OxPal Medlink, UK
- 2Faculty of Medicine, Islamic University of Gaza, occupied Palestinian territory
- 3Vertex Pharmaceuticals, Boston, USA
- 4Harvard T.H. Chan School of Public Health, Boston, USA
- 5Institute for Evidence-Based Healthcare, Faculty of Health Sciences & Medicine, Bond University, Australia
- 6Medical Sciences Division, University of Oxford and OxPal Medlink, UK
- ↵*Corresponding author: Dr Osaid Alser, MD, MSc (Oxon), 165 Cambridge St, Suite 810, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. E-mail: osaidalserr{at}hotmail.com